Mercado europeo del herpes: tendencias de la industria y pronóstico hasta 2028

Personalice su informePersonalice su informe Compre ahoraCompre ahora Ejemplo de informe gratuitoEjemplo de informe gratuito
Hogar Healthcare Europe Herpes Market
Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Mercado europeo del herpes: tendencias de la industria y pronóstico hasta 2028

  • Healthcare
  • Published Report
  • Aug 2021
  • Europe
  • 350 Páginas
  • Número de tablas: 131
  • Número de figuras: 49
Comprar ahoraComprar ahora

>Mercado europeo del herpes, por tipo de virus (herpes simple y herpes zóster), producto (aciclovir, docosanol, valaciclovir, famciclovir y otros), tipo de fármaco (medicamento con receta y fármaco de venta libre), edad (adultos y pediatría), vía de administración (tópica, oral y parenteral), canal de distribución (farmacias de hospitales, farmacias minoristas, droguerías, farmacias en línea y otras), usuarios finales (hospitales, clínicas especializadas y otros), país (Alemania, Francia, Reino Unido, Italia, España, Rusia, Turquía, Bélgica, Países Bajos, Suiza, Luxemburgo y resto de Europa), tendencias de la industria y pronóstico hasta 2028.

Mercado europeo del herpesAnálisis y perspectivas del mercado: mercado del herpes en Europa

Se espera que el mercado europeo del herpes gane un crecimiento significativo en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 6,1% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 437,80 millones para 2028 desde USD 283,76 millones en 2020. La creciente prevalencia de infecciones por herpes y el aumento de la población geriátrica son los principales impulsores, que se espera que impulsen el crecimiento del mercado en el período de pronóstico.

Cada vez hay más personas afectadas por el virus del herpes simple, que exige un tratamiento antiherpético avanzado y altamente eficaz para minimizar el riesgo durante el tratamiento. Los sistemas sanitarios necesitan medicamentos muy avanzados para numerosos tipos diferentes de herpes durante el tratamiento de los pacientes. Por lo tanto, los principales actores del mercado se centran en gran medida en los lanzamientos y las aprobaciones de productos. Además, los gobiernos y los organismos reguladores están apoyando a los actores del mercado en virtud de las aprobaciones de productos.

La creciente prevalencia de enfermedades herpéticas y el aumento del gasto sanitario en todas las regiones han acelerado la necesidad de medicamentos antiherpéticos en los centros sanitarios, lo que está impulsando el crecimiento del mercado del herpes en Europa. Además, el creciente volumen de personas geriátricas está impulsando aún más el crecimiento del mercado. Sin embargo, se prevé que el alto coste de los medicamentos antiherpéticos y las retiradas de productos obstaculicen el crecimiento del mercado en el período proyectado. Por otro lado, las iniciativas estratégicas de los actores del mercado y el creciente número de fabricantes de medicamentos antiherpéticos actúan como una oportunidad para este mercado y se espera que impulsen el crecimiento del mercado. Sin embargo, la interrupción de la cadena de suministro de medicamentos e inyecciones contra el herpes durante la covid-19 y la falta de mano de obra en las industrias farmacéuticas son desafíos clave para este mercado.

The Europe herpes market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Mercado europeo del herpes

The Europe Herpes Market Scope and Market Size

The Europe herpes market is segmented on the basis of virus type, product, drug type, age, route of administration, distribution channel, and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of virus type, the Europe herpes market is segmented into herpes simplex and herpes zoster.  In 2021, herpes simplex segment is expected to dominate the market due to rising prevalence of simplex virus because of less awareness among people regarding the same.  
  • On the basis of product, the Europe herpes market is segmented into acyclovir, docosanol, valacyclovir, famciclovir, and others. In 2021, acyclovir segment is expected to dominate the market because it is a widely used medicine for the treatment of herpes infection.
  • On the basis of drug type, the Europe herpes market is segmented into prescription drug and over-the counter drug. In 2021, prescription drug segment is expected to dominate the market owing to rising incidences of herpes simplex and herpes zoster infections in the region.
  • On the basis of age, the Europe herpes market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market owing to advanced healthcare system for adults, which leads to the increasing life expectancy of people.
  • On the basis of route of administration, the Europe herpes market is segmented into topical, oral, and parenteral. In 2021, topical segment is expected to dominate the market because it provides instant relief from the symptoms.
  • On the basis of distribution channel, the Europe herpes market is segmented into hospitals pharmacies, retail pharmacies, drug stores, online pharmacies, and others. In 2021, hospital pharmacies segment is expected to dominate the market because of rising geriatric population. The increasing pool of geriatric population boosts the market growth by launching new products in the market.
  • On the basis of end-users, the Europe herpes market is segmented into hospital, speciality clinics, and others. In 2021, hospitals segment is expected to dominate the market due to growing awareness among people about the various treatment available for herpes infection.

Europe Herpes Market Country Level Analysis

The Europe herpes market is analyzed and market size information is provided based on virus type, product, drug type, age, route of administration, distribution channel and end users. 

Countries covered in the Europe herpes market report are Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, and Rest of Europe. Germany is dominating the European market owing to large number of players in the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Rising healthcare expenditure and high prevalence of herpes infections in Europe are creating new opportunities for players in the Europe herpes market

Germany is leading the market in Europe region and herpes simplex segment is dominating the country due to rising demand for anti- herpetic drugs.

Europe herpes market also provides you with detailed market analysis for every country growth in particular industry with the Europe herpes market sales, impact of advancement in the Europe herpes market and changes in regulatory scenarios with their support for the Europe herpes market. The data is available for historic period 2010 to 2018. 

Competitive Landscape and Europe herpes market Share Analysis

Europe herpes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to Europe herpes market.

Los principales actores incluidos en el informe son Abbott, Apotex, Inc., Avet Pharmaceuticals, Inc., Bausch Health Companies, Inc., Cipla, Inc., Dr. Reddy's Laboratories Ltd., EPI Health, Fresenius Kabi AG, GlaxoSmithKline plc., Glenmark Pharmaceutical Inc., USA, Maruho Co.,Ltd., Mylan NV, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., RECORDATI SpA, Aurobindo Pharma, Amneal Pharmaceuticals LLC, Slavia Pharm SRL, Blistex, Inc., entre otros actores nacionales y europeos. Los analistas de DBMR comprenden las fortalezas competitivas y brindan un análisis competitivo para cada competidor por separado.

Numerosos lanzamientos de productos y acuerdos son también iniciados por empresas de todo el mundo, lo que está acelerando aún más el crecimiento del mercado del herpes en Europa.

Por ejemplo,

  • En noviembre de 2019, Mylan NV anunció la fusión de la empresa con Upjohn, una división de Pfizer; la nueva empresa formada se llamaría Viatris. La fusión de ambas empresas para desarrollar una empresa combinada ha ampliado su cartera de productos, lo que ha provocado un aumento de la demanda de su producto en el mercado.
  • En septiembre de 2018, Avet Pharmaceuticals Inc. anunció la disponibilidad inmediata de las cápsulas de Acyclovir de 200 mg. Este lanzamiento mejoró la amplia cartera de productos sólidos orales genéricos de Avet. Este nuevo fármaco lanzado por la empresa ha aumentado sus ventas en el mercado.

SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Sample Image Click on image to enlarge
  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE HERPES MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. Virus type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
    1. Summary write up (North America)
      1. OVERVIEW
    2. Summary write up (Europe)
      1. OVERVIEW
    3. Summary write up (Asia-Pacific)
      1. OVERVIEW
    4. Summary write up (South America)
      1. OVERVIEW
    5. Summary write up (Middle East and Africa)
      1. OVERVIEW
  5. Europe HERPES market: regulations
    1. THE U.S. REGULATORY FRAMEWORK
    2. CANADA REGULATORY FRAMEWORK
    3. THE EUROPE REGULATORY FRAMEWORK
    4. INDIA REGULATORY FRAMEWORK
  6. market overview
    1. drivers
    2. INCREASING geriatric population
      1. INCREASE IN prevalence of HERPES infections
      2. INCREASE IN NUMBER OF PRODUCT APPROVALS AND LAUNCHES
      3. RISING NUMBER OF Immunocompromised PEOPLE
    3. Restraints
      1. High cost of Anti-Herpetic medicines
      2. product recall
    4. opportunities
      1. strategic initiatives by the market players
      2. increasing healthcare expenditure
      3. SOARING NUMBER OF anti-herpetic drugs MANUFACTURERS
      4. RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
    5. challenges
      1. disruption in the supply chain of herpes drugs and injections during covid-19
      2. lack of workforce in pharma industries
  7. IMPACT OF COVID-19 ON EUROPE HERPES MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS
    5. CONCLUSION
  8. EUROPE HERPES MARKET, By VIRUS TYPE
    1. overview
    2. herpes simplex
      1. TYPE I
      2. TYPE II
    3. herpes zoster
  9. EUROPE HERPES MARKET, By PRODUCT TYPE
    1. overview
    2. ACYCLOVIR
    3. Docosanol
    4. Valacyclovir
    5. Famciclovir
    6. others
  10. EUROPE HERPES MARKET, By drug type
    1. overview
    2. Prescription Drug
    3. Over-The Counter Drug
  11. Europe HERPES market, By age
    1. overview
    2. adult
    3. pediatrics
  12. Europe herpes market, By ROUTE of administration
    1. overview
    2. topical
    3. oral
    4. Parenteral
  13. Europe herpes market, By DISTRIBUTION CHANNEL
    1. overview
    2. hospitals pharmacies
    3. retail pharmacies
    4. Drug Stores
    5. Online Pharmacies
    6. others
  14. Europe herpes market, By end users
    1. overview
    2. hospitals
    3. Speciality Clinics
    4. Others
  15. EUROPE herpes MARKET, BY REGION
    1. europe
      1. Germany
      2. france
      3. U.K.
      4. Italy
      5. Spain
      6. russia
      7. turkey
      8. belgium
      9. netherlands
      10. switzerland
      11. luxemburg
      12. rest of europe
  16. Europe Herpes Market: COMPANY landscape
    1. company share analysis: Europe
  17. swot analysis
  18. company profile
    1. GLAXOSMITHKILNE PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. Viatris Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    3. Fresenius Kabi AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. pfizer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    6. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. Amneal Pharmaceuticals LLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. apotex inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    10. Avet Pharmaceuticals Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. Bausch Health Companies Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    12. blistex, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. cipla, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. Dr. Reddy’s Laboratories Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    15. EPIHEALTH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. Glenmark Pharmaceutical Inc., USA (A Subsidiary of Glenmark Pharmaceuticals Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    17. Maruho Co.,Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. RECORDATI S.p.A.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    19. Slavia Pharm S.R.L.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    20. Sun Pharmaceutical Industries Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    21. Zydus Pharmaceuticals, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  19. questionnaire
  20. related reports

Lista de Tablas

TABLE 1 The EMA has seven scientific committees that carry out its scientific assessments:

TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 3 MANUFACTURERS OF ANTI-HERPETIC DRUGS

TABLE 4 EUROPE HERPES MARKET, By VIRUS Type, 2019-2028 (USD million)

TABLE 5 Europe Herpes Simplex in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 6 Europe Herpes Simplex in Herpes Market, By Virus Type, 2019-2028 (USD Million)

TABLE 7 Europe Herpes Zoster in Herpes Market, BY Region, 2019-2028 (USD Million)

TABLE 8 Europe Herpes Market, By Product Type, 2019-2028 (USD Million)

TABLE 9 Europe Acyclovir in Herpes Market, BY Region, 2019-2028 (USD Million)

TABLE 10 Europe Docosanol in Herpes Market, By Region, 2019-2028 (USD Million)

TABLE 11 Europe Valacyclovir in Herpes Market, By region, 2019-2028 (USD Million)

TABLE 12 Europe Famciclovir in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 13 Europe Others in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 14 Europe Herpes Market, By Drug Type, 2019-2028 (USD Million)

TABLE 15 Europe prescription drug in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 16 Europe Over-The Counter Drug in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 17 Europe Herpes Market, By Age, 2019-2028 (USD Million)

TABLE 18 Europe Adult in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 19 Europe Pediatrics in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 20 Europe Herpes Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 21 Europe Topical in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 22 Europe Oral in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 23 Europe Parenteral in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 24 Europe Herpes Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 25 Europe Hospitals Pharmacies in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 26 Europe Retail Pharmacies in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 27 Europe Drug Stores in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 28 Europe Online Pharmacies in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 29 Europe Others in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 30 Europe Herpes Market, By End Users, 2019-2028 (USD Million)

TABLE 31 Europe Hospitals in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 32 Europe Speciality Clinics in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 33 Europe Others in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 34 EUROPE HERPES market, By Country, 2019-2028 (USD Million)

TABLE 35 EUROPE HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 36 EUROPE herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 37 EUROPE HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 38 EUROPE HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 39 EUROPE HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 40 EUROPE HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 41 EUROPE HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 42 EUROPE HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 43 GERMANY HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 44 GERMANY herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 45 GERMANY HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 46 GERMANY HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 47 GERMANY HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 48 GERMANY HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 49 GERMANY HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 50 GERMANY HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 51 france HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 52 france herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 53 FRANCE HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 54 FRANCE HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 55 FRANCE HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 56 FRANCE HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 57 FRANCE HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 58 FRANCE HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 59 U.K. HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 60 U.K. herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 61 U.K. HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 62 U.K. HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 63 U.K. HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 64 U.K. HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 65 U.K. HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 66 U.K. HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 67 ITALY HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 68 ITALY herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 69 ITALY HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 70 ITALY HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 71 ITALY HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 72 ITALY HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 73 ITALY HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 74 ITALY HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 75 SPAIN HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 76 SPAIN herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 77 SPAIN HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 78 SPAIN HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 79 SPAIN HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 80 SPAIN HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 81 SPAIN HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 82 SPAIN HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 83 RUSSIA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 84 RUSSIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 85 RUSSIA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 86 RUSSIA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 87 RUSSIA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 88 RUSSIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 89 RUSSIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 90 RUSSIA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 91 TURKEY HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 92 TURKEY herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 93 TURKEY HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 94 TURKEY HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 95 TURKEY HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 96 TURKEY HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 97 TURKEY HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 98 TURKEY HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 99 BELGIUM HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 100 BELGIUM herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 101 BELGIUM HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 102 BELGIUM HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 103 BELGIUM HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 104 BELGIUM HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 105 BELGIUM HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 106 BELGIUM HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 107 netherlands HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 108 NETHERLANDS herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 109 NETHERLANDS HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 110 NETHERLANDS HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 111 NETHERLANDS HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 112 NETHERLANDS HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 113 NETHERLANDS HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 114 NETHERLANDS HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 115 SWITZERLAND HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 116 SWITZERLAND herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 117 SWITZERLAND HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 118 SWITZERLAND HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 119 SWITZERLAND HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 120 SWITZERLAND HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 121 SWITZERLAND HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 122 SWITZERLAND HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 123 LUXEMBURG HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 124 LUXEMBURG herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 125 LUXEMBURG HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 126 LUXEMBURG HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 127 LUXEMBURG HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 128 LUXEMBURG HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 129 LUXEMBURG HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 130 LUXEMBURG HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 131 rest of europe HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

Lista de figuras

FIGURE 1 EUROPE HERPES MARKET: segmentation

FIGURE 2 EUROPE HERPES MARKET: data triangulation

FIGURE 3 EUROPE HERPES MARKET: DROC ANALYSIS

FIGURE 4 EUROPE HERPES MARKET: Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE HERPES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE HERPES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE HERPES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE HERPES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 EUROPE HERPES MARKET: vendor share analysis

FIGURE 10 EUROPE HERPES MARKET: SEGMENTATION

FIGURE 11 increasE IN prevalence of herpes infections and rise in healthcare expenditure are expected to drive THE EUROPE HERPES MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 herpes simplex segment is expected to account for the largest share of the EUROPE HERPES MARKET in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF Europe Herpes market

FIGURE 14 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)

FIGURE 15 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)

FIGURE 16 EUROPE HERPES MARKET : By VIRUS TYPE, 2020

FIGURE 17 EUROPE HERPES MARKET : By VIRUS TYPE, 2019-2028 (USD million)

FIGURE 18 EUROPE HERPES MARKET : By VIRUS TYPE, CAGR (2021-2028)

FIGURE 19 EUROPE HERPES MARKET : By VIRUS TYPE, LIFELINE CURVE

FIGURE 20 EUROPE HERPES MARKET : By PRODUCT TYPE, 2020

FIGURE 21 EUROPE HERPES MARKET : By PRODUCT TYPE, 2019-2028 (USD million)

FIGURE 22 EUROPE HERPES MARKET : By PRODUCT TYPE, CAGR (2021-2028)

FIGURE 23 EUROPE HERPES MARKET : By PRODUCT TYPE, LIFELINE CURVE

FIGURE 24 EUROPE HERPES MARKET : By DRUG TYPE, 2020

FIGURE 25 EUROPE HERPES MARKET : By DRUG TYPE, 2019-2028 (USD million)

FIGURE 26 EUROPE HERPES MARKET : By DRUG TYPE, CAGR (2021-2028)

FIGURE 27 EUROPE HERPES MARKET : By DRUG TYPE, LIFELINE CURVE

FIGURE 28 EUROPE HERPES MARKET: By AGE, 2020

FIGURE 29 EUROPE HERPES MARKET: By AGE, 2019-2028 (USD million)

FIGURE 30 EUROPE HERPES MARKET: By AGE, CAGR (2021-2028)

FIGURE 31 EUROPE HERPES MARKET: By AGE, LIFELINE CURVE

FIGURE 32 Europe herpes market: By route OF administration, 2020

FIGURE 33 Europe HERPES market: By route OF ADMINISTRATION, 2019-2028 (USD million)

FIGURE 34 Europe HERPES market: By route OF ADMINISTRATION, CAGR (2021-2028)

FIGURE 35 Europe HERPES market: By route OF ADMINISTRATION, LIFELINE CURVE

FIGURE 36 Europe herpes market: distribution channel, 2020

FIGURE 37 Europe herpes market: DISTRIBUTION CHANNEL, 2019-2028 (USD million)

FIGURE 38 Europe herpes market: DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 39 Europe herpes Europe market: DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 40 Europe herpes market: By end users, 2020

FIGURE 41 Europe herpes market: Byend users, 2019-2028 (USD million)

FIGURE 42 Europe herpes market: By end users, CAGR (2021-2028)

FIGURE 43 Europe herpes market: By end users, LIFELINE CURVE

FIGURE 44 EUROPE HERPES MARKET: SNAPSHOT (2020)

FIGURE 45 EUROPE HERPES MARKET: BY COUNTRY (2020)

FIGURE 46 EUROPE HERPES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 47 EUROPE HERPES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 EUROPE HERPES MARKET: BY virus TYPE (2021-2028)

FIGURE 49 EUROPE HERPES MARKET: COMPANY SHARE 2020 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Preguntas frecuentes

The Europe Herpes Market Growth Rate Will Be 6.1% by 2028
The Europe Herpes Market Will be Worth USD 437.80 million by 2028.
The major companies in the Europe Herpes Market are bbott, Apotex, Inc., Avet Pharmaceuticals, Inc., Bausch Health Companies, Inc. Cipla, Inc., Dr. Reddy’s Laboratories Ltd., EPI Health, Fresenius Kabi AG, GlaxoSmithKline plc., Glenmark Pharmaceutical Inc., USA, Maruho Co., Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., RECORDATI S.p.A., Aurobindo Pharma, Amneal Pharmaceuticals LLC, Slavia Pharm S.R.L., Blistex, Inc etc.
The type, product, drug type, age, route of administration, distribution channel, and end users re the factors on which the Europe Herpes Market Research is based.
The major data pointers of the Europe Herpes Market are new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs.

Explorar páginas relacionadas

Banner